UCDCC#271: Phase I/II Trial of Epacadostat, Intralesional SD101, Radiotherapy in Patients With Lymphoma

NCT03322384 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumors
Lymphoma

Interventions

DRUG: epacadostat
DRUG: SD-101
RADIATION: Radiotherapy

Sponsor

University of California, Davis